Jing Wang

Company: Eli Lilly & Co.

Job title: Director

Seminars:

Panel Discussion: From Hype to Impact – Realizing the Value of AI in Biologics Design 3:15 pm

What are the current limitations and tangible successes in applying AI/ML to biologics discovery and developability? How are organizations measuring ROI from computational investments — speed, cost, accuracy, or all three? What infrastructure, culture, and talent are needed to effectively scale AI adoption across discovery and development pipelines?Read more

day: Conference Day One

Computational Approaches to Enable Challenge GPCR Agonist 2:45 pm

Apply structure-based and AI-driven methods to identify and optimize novel GPCR agonists with improved specificity Leverage predictive modeling and AI-based protein design to address limited GPCR structural data Accelerate GPCR-targeted drug discovery by integrating virtual screening with ligand-receptor interaction analysisRead more

day: Conference Day One